Featured Job
-
Job Removed or Not Found
Related Jobs
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …for Development : Manages multiple CMC development projects. Leads submission teams with supervision. Acts as point of contact to cross-functional teams on US/EU RA CMC
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …CDx development : Provide critical strategic and tactical regulatory guidance for CDx/IVD development and CDx submission plan for each country/region, both before and
- Eisai, Inc (Nutley, NJ)
- …collate and distribute Congress Report, execute pre- and post-congress educational sessions.Maintain and update the Eisai Medical Affairs College platform to ensure a
- Daiichi Sankyo, Inc. (Bernards, NJ)
- Join a Legacy of Innovation 125 Years and Counting! Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve
- Piper Companies (Minneapolis, MN)
- …of the Associate Director, Regulatory Affairs: Lead regulatory documentation and submissions for product development, ensuring compliance with industry standards and
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.Education Qualifications (from an accredited college or
- Abbott (Alameda, CA)
- …About Abbott Abbott is a global healthcare leader, creating breakthrough science to improve people's health. We're always looking towards the future, anticipating changes
- Kura Oncology (Boston, MA)
- Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology,
- Eisai, Inc (Nutley, NJ)
- …without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran
- Merck & Co. (Rahway, NJ)
- …also include development of American Managed Care Pharmacy (AMCP) dossiers for US payers, and Global Value Dossiers for use by local subsidiaries in their HTA
